Just one other small thing I noticed:
The current Her-vaxx Phase 2 trial has acquired a groovy new name - "HERIZON" - as featured in the recent ASCO and ESMO conference presentations and the related article in the Journal of Clinical Oncology - https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.e16065
Along with the recent appointment of Monil Shah as Chief Business Officer, I see this as a sign that Imugene is sharpening its marketing....
Cheers
Dave
Media Thread, page-2207
-
- There are more pages in this discussion • 13,343 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $1.098M | 21.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 97 | 7481668 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 1703097 | 4 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |